Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 703,971 | 222,200 | 178,844 | 298,017 | 447,229 |
| Cost of Goods | 15,204 | N/A | N/A | N/A | N/A |
| Gross Profit | 688,767 | 222,200 | 178,844 | 298,017 | 447,229 |
| Operating Expenses | 479,679 | 1,047,171 | 485,988 | 643,846 | 655,861 |
| Operating Income | 209,292 | -824,971 | -307,144 | -345,829 | -208,632 |
| Interest Expense | 4,876 | 5,138 | 5,182 | 5,968 | 4,839 |
| Other Income | 1,654 | 434 | -4,064 | 3,028 | -6,231 |
| Pre-tax Income | 206,070 | -829,675 | -316,390 | -348,769 | -219,702 |
| Income Tax | 2,662 | 16,609 | 6,041 | 3,548 | 3,017 |
| Net Income Continuous | 203,408 | -846,284 | -322,431 | -352,317 | -222,719 |
| Net Income | $203,408 | $-846,284 | $-322,431 | $-352,317 | $-222,719 |
| EPS Basic Total Ops | 2.66 | -11.33 | -4.31 | -4.75 | -3.05 |
| EPS Basic Continuous Ops | 2.66 | -11.32 | -4.31 | -4.75 | -3.05 |
| EPS Diluted Total Ops | 2.56 | -11.33 | -4.31 | -4.75 | -3.05 |
| EPS Diluted Continuous Ops | 2.52 | -11.32 | -4.31 | -4.75 | -3.05 |
| EBITDA(a) | $216,057 | $-821,299 | $-302,882 | $-343,419 | $-206,315 |